🔎 Trials Near Me

Akèy › Kondisyon Post-COVID (Long COVID) › Maryland

Etid klinik pou Kondisyon Post-COVID (Long COVID) nan Maryland

21 etid pou Kondisyon Post-COVID (Long COVID) ap chèche patisipan nan sit nan Maryland.

Vil nan Maryland

Tèks ofisyèl etid la (Anglè)

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

  • Annapolis Internal Medicine - CCT Research ( Site 3700), Annapolis
  • Kur Research - Columbia Medical ( Site 3767), Columbia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06667700

A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

  • University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT07536308

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Annapolis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05624450

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Johns Hopkins Hospital, Baltimore
  • Jadestone Clinical Research, Silver Spring
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07013474

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Centennial Medical Group, Columbia
  • Jadestone Clinical Research, Silver Spring
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06679140

Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 110 · Tout sèks · Mizajou Sep 16, 2026 · NCT06577467

Viral Infections in Healthy and Immunocompromised Hosts

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
6 Months – 120 Years · Tout sèks · Mizajou Sep 14, 2026 · NCT01306084

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT04573062

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

  • Niaid/Lcim, Rockville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 99 Years · Tout sèks · Mizajou Sep 9, 2026 · NCT04582903

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Aug 18, 2026 · NCT06920628

Respiratory Virus Sampling and Repository

  • National Institutes of Health Clinical Center, Bethesda
  • NIH Building 33 (NIAID), Bethesda
Ap rekriteEtid obsèvasyon
Laj 3 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05266222

Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome

  • University of Maryland, Baltimore, Baltimore
Ap rekrite
Laj 50 a 94 · Tout sèks · Mizajou Jun 23, 2026 · NCT05977179

Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Ap rekriteVolontè an sante akeyi
Jiska laj 80 · Tout sèks · Mizajou Jun 1, 2026 · NCT05880108

The Impact of COVID-19 on Maternal and Neonatal Outcomes

  • Johns Hopkins Hospital, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 14 a 55 · Fanm · Mizajou May 11, 2026 · NCT05197621

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore
Ap rekriteFaz 1
Laj 2 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT05141058

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

  • Kennedy Krieger Institute, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Dec 12, 2025 · NCT07278388

Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities

  • Johns Hopkins University, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT06128928

Home-Based Exercise Tele-Rehabilitation After COVID-19

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 50 a 85 · Tout sèks · Mizajou Nov 10, 2025 · NCT05425264

Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

  • All Natural Medicine Clinic, LLC, Rockville
Ap rekriteFaz 1/2
Tout laj · Tout sèks · Mizajou Feb 19, 2025 · NCT04790240

Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

  • NIH Clinical Center, Bethesda
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Nov 27, 2024 · NCT06441955

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.